Клинический случай легочной формы мукормикоза у ребенка с острым лимфобластным лейкозом
Dmitriy Akimovich Kharagezov, Yu. N. Lazutin, Мирзоян Эллада Арменовна et al. · South Russian Journal of Cancer · 2021
The article presents a clinical case of pulmonary mucormycosis in a 12‑year-old child at the stage of diagnosis of acute lymphoblastic leukemia. The first symptoms of the disease (headaches, malaise and weakness, pallor), changes in the general blood count (hyperleukocytosis up to 200 thousand cells/μl, single platelets). Based on the results of the examination, the main diagnosis was verified for acute lymphoblastic leukemia L2, IFT T-II, CD1a-. At the stage of diagnosis of acute lymphoblastic leukemia, the underlying disease was complicated by the development of right-sided pneumonia according to X-ray examination. To verify the etiology of infiltration of lung tissue, broncho-alveolar lavage was directed to microbiological diagnostics, which included studies: enzyme immunoassay, microscopic and cultural. On the aggregate of all the results obtained, invasive mucormycosis was diagnosed and antifungal therapy was started immediately.
Cited by 5 works. doi:10.37748/2686-9039-2021-2-4-5
Authors
- Dmitriy Akimovich Kharagezov
- Yu. N. Lazutin
- Мирзоян Эллада Арменовна
- Anton Grigor'evich Milakin
- O. N. Stateshny
- Igor' Aleksandrovich Leyman
- Чубарян Анна Васильевна
- Иозефи Кристиан Дмитриевич
References
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
- The landscape of kinase fusions in cancer
- A Comprehensive Survey of Ras Mutations in Cancer
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer